Plain-English translation of NCT07573956 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
After surgery for head and neck cancer, patients typically receive 6 weeks of radiation therapy to kill any remaining cancer cells. This trial is testing whether a faster schedule — just 3 weeks of radiation therapy — works just as well, with fewer side effects. The shorter treatment could make things more convenient for patients and help use medical resources more wisely.
Standard radiation therapy takes 6 weeks and requires many visits to the hospital, which is hard on patients and uses a lot of medical resources. Newer radiation techniques are now precise enough that doctors believe a shorter, 3-week schedule might work just as well without causing more harm, especially in countries where cancer care resources are limited.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to receive either the standard 6-week radiation schedule (30 treatments over 6 weeks) or the faster 3-week schedule (15 treatments over 3 weeks). Both use advanced, precise radiation techniques to target cancer while protecting healthy tissue nearby. You'll have regular follow-up visits to check how well the treatment worked and to monitor for any side effects.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
India